Stefania Chiappini

3.2k total citations · 1 hit paper
81 papers, 1.9k citations indexed

About

Stefania Chiappini is a scholar working on Clinical Psychology, Pharmacology and Toxicology. According to data from OpenAlex, Stefania Chiappini has authored 81 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Clinical Psychology, 27 papers in Pharmacology and 27 papers in Toxicology. Recurrent topics in Stefania Chiappini's work include Psychedelics and Drug Studies (19 papers), Forensic Toxicology and Drug Analysis (19 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Stefania Chiappini is often cited by papers focused on Psychedelics and Drug Studies (19 papers), Forensic Toxicology and Drug Analysis (19 papers) and Neurotransmitter Receptor Influence on Behavior (15 papers). Stefania Chiappini collaborates with scholars based in Italy, United Kingdom and United States. Stefania Chiappini's co-authors include Fabrizio Schifano, John Corkery, Amira Guirguis, Giovanni Martinotti, Mauro Pettorruso, Laura Orsolini, A Ricciardi, Andrea Miuli, Domenico De Berardis and Alessio Mosca and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Stefania Chiappini

73 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis

2024 35 citations Amira Guirguis, Stefania Chiappini et al. European Neuropsychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stefania Chiappini Italy	28	598	557	443	333	323	81	1.9k
Amira Guirguis United Kingdom	25	295 0.5×	523 0.9×	544 1.2×	198 0.6×	298 0.9×	77	1.7k
Derek K. Tracy United Kingdom	28	344 0.6×	799 1.4×	293 0.7×	717 2.2×	421 1.3×	141	2.6k
Francina Fonseca Spain	21	239 0.4×	392 0.7×	290 0.7×	173 0.5×	355 1.1×	80	1.4k
Erik W. Gunderson United States	19	679 1.1×	328 0.6×	536 1.2×	103 0.3×	458 1.4×	31	1.5k
Udo Bonnet Germany	27	612 1.0×	214 0.4×	145 0.3×	452 1.4×	606 1.9×	130	2.2k
Matthew J. Baggott United States	20	377 0.6×	632 1.1×	350 0.8×	110 0.3×	475 1.5×	36	1.4k
John Mendelson United States	31	664 1.1×	479 0.9×	725 1.6×	189 0.6×	862 2.7×	71	2.8k
Jørgen G. Bramness Norway	34	708 1.2×	777 1.4×	471 1.1×	917 2.8×	384 1.2×	232	4.0k
Robert S. Goodwin United States	23	1.4k 2.3×	400 0.7×	760 1.7×	234 0.7×	524 1.6×	38	4.0k
Benjamin Rolland France	28	497 0.8×	760 1.4×	230 0.5×	634 1.9×	442 1.4×	183	3.5k

Countries citing papers authored by Stefania Chiappini

Since Specialization

Citations

This map shows the geographic impact of Stefania Chiappini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Chiappini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Chiappini more than expected).

Fields of papers citing papers by Stefania Chiappini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefania Chiappini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Chiappini. The network helps show where Stefania Chiappini may publish in the future.

Co-authorship network of co-authors of Stefania Chiappini

This figure shows the co-authorship network connecting the top 25 collaborators of Stefania Chiappini. A scholar is included among the top collaborators of Stefania Chiappini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefania Chiappini. Stefania Chiappini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chiappini, Stefania, et al.. (2025). Management of Insomnia Associated with Chronic Stimulant Use: A Systematic Review of Pharmacological and Non-Pharmacological Interventions. Psychiatry International. 6(4). 121–121.

Mosca, Alessio, Stefania Chiappini, Andrea Miuli, et al.. (2025). Eco-Anxiety and Mental Health: Correlates of Climate Change Distress. International Journal of Environmental Research and Public Health. 22(12). 1768–1768.

Chiappini, Stefania, Alessio Mosca, Denis Pelletier, et al.. (2025). Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data. Journal of Clinical Medicine. 14(10). 3461–3461.

Chiappini, Stefania, Andrea Miuli, Giacomo d’Andrea, et al.. (2025). Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review. 1(1).

Montemitro, Chiara, Alessio Mosca, Stefania Chiappini, et al.. (2024). Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain. Pharmaceuticals. 17(10). 1387–1387. 1 indexed citations

Guirguis, Amira, Stefania Chiappini, Rachel Vickers‐Smith, et al.. (2024). Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis. European Neuropsychopharmacology. 82. 82–91. 35 indexed citations breakdown →

Pepe, Maria, Marco Di Nicola, Fabrizio Cocciolillo, et al.. (2024). 3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report. Pharmaceuticals. 17(4). 452–452. 3 indexed citations

Chiappini, Stefania, Alessio Mosca, Francesco Di Carlo, et al.. (2024). Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study. Pharmaceuticals. 17(4). 535–535. 12 indexed citations

Mosca, Alessio, Stefania Chiappini, Andrea Miuli, et al.. (2024). Piperazine Abuse and Psychosis: A Systematic Review of the Literature. SHILAP Revista de lepidopterología. 5(3). 552–563. 1 indexed citations

10.

d’Andrea, Giacomo, Mauro Pettorruso, Giorgio Di Lorenzo, et al.. (2023). The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data. Journal of Affective Disorders. 348. 314–322. 32 indexed citations

11.

Chiappini, Stefania, Rachel Vickers‐Smith, Daniel R. Harris, et al.. (2023). Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. Pharmaceuticals. 16(7). 994–994. 39 indexed citations

12.

Chiappini, Stefania, Alessio Mosca, Andrea Miuli, et al.. (2022). Misuse of Anticholinergic Medications: A Systematic Review. Biomedicines. 10(2). 355–355. 16 indexed citations

13.

Chiappini, Stefania, Rachel Vickers‐Smith, Amira Guirguis, et al.. (2022). Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). Pharmaceuticals. 15(6). 675–675. 21 indexed citations

14.

Corkery, John, Amira Guirguis, Stefania Chiappini, Giovanni Martinotti, & Fabrizio Schifano. (2022). Alprazolam-related deaths in Scotland, 2004–2020. Journal of Psychopharmacology. 36(9). 1020–1035. 12 indexed citations

15.

Chiappini, Stefania, Rachel Vickers‐Smith, Amira Guirguis, et al.. (2022). A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. Pharmaceuticals. 15(5). 565–565. 18 indexed citations

16.

Schifano, Nicolò, Paolo Capogrosso, Luca Boeri, et al.. (2022). Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases. International Journal of Impotence Research. 35(5). 465–471. 7 indexed citations

17.

Chiappini, Stefania, Alessio Mosca, Andrea Miuli, et al.. (2021). New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Medicina. 57(6). 580–580. 36 indexed citations

18.

Chiappini, Stefania, Fabrizio Schifano, John Corkery, & Amira Guirguis. (2021). Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. Journal of Psychopharmacology. 35(6). 681–692. 30 indexed citations

19.

Chiappini, Stefania, Fabrizio Schifano, John Corkery, & Amira Guirguis. (2020). Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database. Brain Sciences. 10(2). 105–105. 24 indexed citations

20.

Orsolini, Laura, Stefania Chiappini, Umberto Volpe, et al.. (2019). Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. Medicina. 55(9). 525–525. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact